LIVER AND PANCREAS BIOPSY Solicitation ID/Procurement Identifier: 36C24921Q0094 Ultimate Completion Date: Sat Mar 14 17:00:00 GMT 2026
This blood panel should include but is not limited to detection screening for multiple cancers such as: Adrenal Cortical Carcinoma, Ampulla of Vater, Anus, Appendix Carcinoma, Bile Ducts, Intrahepatic Bladder, Urinary Bone, Breast, Cervix, Colon and Rectum, Esophagus and Esophagogastric Junction, Gallbladder, Gastrointestinal Stromal Tumor, Gestational Trophoblastic Neoplasms, Kidney, Larynx, Leukemia, Liver, Lung, Lymphoma (Hodgkin and Non Hodgkin
The need for additional medications to treat those affected by AUD is urgently needed.In addition,alcohol misuseaffects virtually all tissues and is linked with dysfunction and failure of many organs and systems including the liver, heart, pancreas, lung, bone, and skeletal muscle, as well as digestive, vascular, endocrine, and immune systems.There are currently no FDA-approved therapies for alcohol-associated organ damage (AAOD) so effectivetherapies
Includes the following anatomy: Anatomically correct rib cage Anatomically correct spine Anatomically correct pelvis bone Anatomically correct Heart phantom (2 Atria, 2 Ventricles, and 4 Valves) Aorta Vena cava Esophagus tube Realistic liver, kidney, and Lungs Large & small Intestines, and bladder Stomach & diaphragm Spleen & Pancreas Psoas Major Muscles No gray market or remanufactured items will be acceptable.
Specific tissues for which biomarkers shall be identified and curated may include liver, kidney, heart, lung, thyroid, spleen, skeletal muscle, gastrointestinal tract, testis, adrenal gland, ovaries, uterus, pancreas, bone marrow, and blood. Genes shall be identified with associated publications cited along with known eliciting agents (i.e., chemical treatments, dietary modifications, genetic models).
per year; 100 primary hepatocellular liver carcinomas (HCC) cases per year; 150 chronic liver disease (CLD) cases per year; 100 primary pancreatic ductal adenocarcinoma cases per year; 50 chronic pancreatitis cases per year; 40 breast cancer patients scheduled for surgery per year; 225 normal population control subjects per year; and accrue cancer patients willing to participate in research but who do not qualify for specific aforementioned studies
The Institute's Division of Intramural Research encompasses the broad spectrum of metabolic diseases such as diabetes, obesity, inborn errors of metabolism, endocrine disorders, mineral metabolism, digestive and liver diseases, nutrition, urology and renal disease, and hematology.
